ロード中...
High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
BACKGROUND: Primary percutaneous coronary intervention (PCI) has been shown to be an effective therapy for patients with acute myocardial infarction (MI). Glycoprotein (GP) IIb/IIIa receptor blockers reduce thrombotic complications in patients undergoing PCI. Most available data relate to Reopro, wh...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3503360/ https://ncbi.nlm.nih.gov/pubmed/23181175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1995-705X.102145 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|